BACKGROUND: Atrial myxoma is the most common type of primary cardiac tumor. The number of studies examining the possible role of blood groups in cardiovascular diseases is increasing. Our aim was to demonstrate the distribution of ABO and Rh blood groups in a large population of patients with atrial myxoma in Iran.
METHODS: In a case-control study design, 35,192 patients undergoing cardiac surgery in a tertiary heart care center in Iran were retrospectively reviewed. Demographic and clinical characteristics of patients with histologically confirmed diagnosis of cardiac myxoma were recorded. Control group consisted of age, gender and year of surgery matched 468 non-cardiac myxoma patients.
RESULTS: Of the 117 patients with cardiac myxoma, 64 patients (54.7%) were female. Blood group A and O were the most frequent blood types (42.7% and 30.8%, respectively) as well as Rh+ group (82.1%) in the cardiac myxoma group, and blood group O and A were the most frequent blood types (37.8% and 32.8%, respectively) as well as Rh+ group (87.8%) in the control group, although the differences were not statistically significant (p>0.05). There was no significant difference between different ABO blood groups and Rh status for tumor size, family history, recurrence, and mortality rate (p>0.05).
CONCLUSION: Blood group A and O and Rh+ status are equally prevalent in patients with and without cardiac myxoma. Whether blood groups have an effect on mortality of patients with cardiac myxoma remains to be seen.